09:22 AM EDT, 10/06/2025 (MT Newswires) -- Health care stocks were edging higher pre-bell Monday, with The Health Care Select Sector SPDR Fund ( XLV ) and iShares Biotechnology ETF (IBB) advancing by 0.2%.

Abivax ( ABVX ) shares were up more than 7% after the company said results from two clinical trials showed that a 50-milligram daily dose regimen of its potential moderate-to-severely active ulcerative colitis treatment obefazimod met its primary endpoint of clinical remission at week eight.

Sarepta Therapeutics ( SRPT ) stock was up more than 3% after the company announced that it will present at the 30th Annual Congress of the World Muscle Society 2025 Congress, taking place on Oct. 7 to 11 in Vienna, Austria.

Arvinas ( ARVN ) shares were up 3% after the company said its ARV-102 experimental drug was well tolerated in both healthy volunteers and patients with Parkinson's disease in two phase 1 trials.